Profiles of BBDC Members Primarily Involved In Diabetes Research

Search for Name or Keyword


Booth, Gillian L. - MD, FRCPC

University of Toronto Appointment(s): Associate Professor, Department of Medicine, Division of Endocrinology & Metabolism; and Department of Health Policy, Management and Evaluation

Other Appointment(s):  

Contact Information:
Li Ka Shing Knowledge Institute
209 Victoria Street
Toronto, ON   M5B 1T8

Phone: (416) 864-6060 Ext: 77448
Fax: (416) 864-3025

Diabetes Related Research Activities:

My research focuses on health outcomes and quality of care related to diabetes. Specific interests include: 1) how neighbourhood characteristics (e.g. community design, the food environment) contribute to the prevalence of obesity and diabetes; 2) gender, socioeconomic, and regional differences in diabetes outcomes; 3) health care strategies to improve the quality of diabetes care and 4) the application of geographic analytic tools to health care planning. Much of this work is done using linkage of large secondary databases including provincial administrative health care data, population-based surveys and census, retail and other environmental data sources. Students and research fellows use epidemiological and health services research methods to study diabetes and its outcomes at a population-level.

View Publications

Brubaker, Patricia L. - PhD

University of Toronto Appointment(s): Professor, Departments of Physiology and Medicine

Other Appointment(s): Staff Scientist, Division of Endocrinology & Metabolism

Contact Information:
Room 3366, Medical Sciences Building
1 King's College Circle
Toronto, ON   M5S 1A8

Phone: (416) 978-2593
Fax: (416) 978-4373

Diabetes Related Research Activities:

The major interests of the Brubaker laboratory relate to the synthesis, secretion and biological activities of gut hormones and, in particular, the intestinal glucagon-like peptides, GLP-1 and GLP-2. These hormones play important roles in the regulation insulin and glucagon secretion, beta cell proliferation, intestinal growth and function, and food intake. GLP-1 mimetics are currently in use for the treatment of patients with Type 2 diabetes, while a long-acting GLP-2 analog has recently been approved for the treatment of patients with intestinal insufficiency due to short bowel. Some of the areas that are currently under investigation in the lab include:

1) Regulation of GLP-1 and GLP-2 synthesis and secretion by the intestine, with particular focus on dietary nutrients and intracellular signalling pathways; and
2) Mechanisms of action of GLP-1 and GLP-2 to stimulate beta cell and intestinal growth, respectively, with a major emphasis on the roles of novel intra- and extracellular mediators of these effects, as well as possible carcinogenic effects.

Students and fellows utilize a wide-variety of approaches to investigate the physiology and pathophysiology of the glucagon-like peptides, including normal and genetically-modified animals, cell culture and imaging approaches, in combination with tissue and cellular analyses at the mRNA and protein level

View Publications

Cafazzo, Joseph - PhD, PEng

University of Toronto Appointment(s): Associate Professor, Institute of Health Policy, Management and Evaluation, Faculty of Medicine
Associate Professor, Institute of Biomaterials and Biomedical Engineering, Faculty of Medicine

Other Appointment(s):

  • Senior Director, Medical Engineering and Healthcare Human Factors, University Health Network
  • Lead, Centre for Global eHealth Innovation, University Health Network
  • Primary Area of Study (PAS) Lead, eHealth Innovation and Information Management, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto
  • Clinical Lead, Design and Engineering for Health, Techna Institute, University Health Network
  • Investigator, Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto
  • Core Member, Centre for Patient Safety, University of Toronto

Contact Information:
RFE 4th Floor, 4S427
190 Elizabeth Street
Toronto, ON   M5G 2C4

Phone: (416) 340-3634

Diabetes Related Research Activities:

Dr. Cafazzo leads the development of technologies as a way to keep people out of hospital by allowing for self-care at home for those with chronic conditions such as diabetes, asthma, end-stage renal disease and congestive heart failure.

These strategies are aimed at helping people before their conditions become acute and medical intervention is required. The emphasis here is improving patient self-efficacy.

One such solution is bantDesigned for adolescents with Type I diabities, bant simplifies diabetes management by connecting to a glucometer via Bluetooth. It also connects teens in a secure community of peers and helps them self-manage by rewarding positive behaviour every time they use their glucometer.

View Publications

Carlen, Peter - MD, FRCPC

University of Toronto Appointment(s): Professor, Department of Medicine, Division of Neurology; Professor, Departments of Physiology, and IBBME

Other Appointment(s): Senior scientist TWRI

Contact Information:
Toronto Western Research Institute
399 Bathurst St., Room 12-413
Toronto, ON   M5T 2S8

Phone: (416) 603-5017
Fax: (416) 603-5768

Diabetes Related Research Activities:

Main interests are mechanisms of neural synchrony and entrainment (epilepsy), hypoglycemic seizures, and neurodegenerative processes.a) We have several projects on cellular mechanisms and local system dynamics of epilepsy, particularly the biophysics of the transition to seizure, and the role of electrotonic coupling via gap junctions. Molecular biological and cellular electrophysiological techniques are being used to measure the upregulation of gap junctions in several in vitro and in vivo seizure models. b) Hypoglycemic seizures are a major problem in juveniles with diabetes. We are studying the pathophysiology of hypoglycaemic seizures in juvenile animals both in vitro and in vivo, noting that the most severe seizures seem to be associated with mainly subcortical seizure-like EEG activity, which could also be related to the 'dead in bed' or sudden unexplained death sometimes noted with juvenile hypoglycemic events. Also we are examining the pathophysiology of neuronal injury which is enhanced by glucose reperfusion. Glucose reperfusion is also associated with a significant upregulation of gap junctional expression, the significance of which remains to be elucidated. However is is known that provision of nutrients to neurons requires intact astrocytic gap junctional communication.

View Publications

Cherney, David - MD, PhD, FRCPC

University of Toronto Appointment(s): Assistant Professor, Department of Medicine, Division of Nephrology

Other Appointment(s): Clinician Scientist, University Health Network

Contact Information:
University Health Network
585 University Ave., Room 8N-845
Toronto, ON   M5G 2N2

Phone: (416) 340-4151
Fax: (416) 340-4999

Diabetes Related Research Activities:

Current research interests in type 1 diabetes mellitus include the physiology of renal hyperfiltration in diabetic nephropathy, cardiorenal interactions and endothelial function, the effect of pharmaceutical agents on the urinary proteome, and functional gene polymorphisms in humans.

View Publications

Records 11 to 15 of 136
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 > >> page(s)